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Abstract
The authors present evidence for a novel, new hypothesis whereby magnesium deficiency (MgD) acts as a
genotoxic agent which probably causes numerous, hertofore, unrecognized consequences, even over a short-term,
on the physiological, molecular and biochemical machinery of cardiovascular tissues and cells. The end result of
these genotoxic effects of MgD probably plays important roles in the etiology and generation of diverse
cardiovascular diseases, atherosclerosis, inflammation, and strokes via alterations in the epigenome of
cardiovascular tissues and cells. The importance of adequate water-borne and dietary levels of Mg is emphasized.
Keywords: Hypertension; Inflammation; Sphingolipids; Ceramide;
Epigenetics
Introduction
Over the past two decades, a considerable amount of research has
taken place around the globe suggesting that a variety of chemicals and
mutagens can produce genotoxic effects in multiple tissues and cells
[1,2 ]. Genotoxicity conotes in genetics a destructive effect(s) on a cell's
genetic material (i.e., DNA, RNA) thus potentially altering cell
integrity, functions, and phenotype [1].
Genotoxins are, thus, mutagens. Some of these well-known
genotoxins include radiation of different types and chemicals known to
damage DNA. The end result of genotoxins result in modification of
gene expression. Although numerous advances are being made about
genotoxins, very little is known about the potential mechanisms
involved in how genotoxins induce lesions in DNA and how these
agents could result in chromosomal abberations.
Recently, we have provided putative evidence that magnesium (Mg)
- deficient environments can act like genotoxins on cardiovascular
tissues and cells [3,4]. We provide, below, background, evidence, and
our reasons for believing that magnesium deficiency(MgD) can result
in genotoxicity in cardiovascular tissues and cells which probably play
major roles in etiology of cardiac diseases, atherogenesis,
inflammation, and stroke heretofore unexplained.
Disturbances in Diets and Magnesium Deficiency
Linked to Cardiac Diseases, Atherogenesis,
Inflammation, and Stroke
Disturbances in diets are known to promote lipid deposition and
accelerate the growth and transformation of smooth muscle and
endothelial cells in the vascular walls of blood vessels and promote
vascular and cardiac dysfunctions of several types; e.g., atherosclerosis,
heart rhythm disturbances, decreases in cardiac ejection of blood,
decreased force of ventricular and atrial contractility, decreases in
arterial blood pressure, diminished venous return to the heart, cardiac
tamponade, hypertension, strokes, sudden-cardiac death, myocardial
infarctions, etc. [5-7]. A number of epidemiologic studies in North
America and Europe have shown that people consuming Western-type
diets are low in magnesium(Mg) content (i.e., 30-65% of the RDA for
Mg) [7-11]. Most of these diets in the U.S.A. show that 60-80% of
Americans are consuming 185-235 mg/day of Mg [6,10]. In 1900, in
contrast, Americans were consuming 450-550 mg/day of Mg [6,8].
Low Mg content of drinking water, found in areas of soft-water and
Mg-poor soil, is associated with high incidences of atherosclerosis,
ischemic heart disease(IHD), coronary vasospasm, hypertension, and
sudden-cardiac death(SCD)[6,8,12-17]. Both animal and human
studies have demonstrated an inverse relationship between dietary
intake of Mg and atherosclerosis [5,6,8,18-21]. The myocardial level of
Mg has consistently been observed to be lower in subjects dying from
IHD and SCD in soft-water areas than those in hard-water
areas[5,6,8,12,13,15,18,22]. Mg plays essential roles in more than 500
enzymatic reactions in the body [23] and is required for all energy-
generating reactions and oxidative phosphorylation [23,24].
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More than 45 years ago, two of us demonstrated that Mg2+ behaves
as a natural calcium channel blocker in both cardiac and vascular
smooth muscle (VSM) cells [8,12,22,24-29]. We also showed in
experimental animals that Mg behaves as a natural statin in that it can
lower blood cholesterol and triglyceride levels [6,8,18,19,30] as well as
act as a powerful vasodilator in the microcirculation and as a cardiac
muscle relaxant [8,18,26,27,31-35]. Hypermagnesemic diets have been
shown to ameliorate hypertension and atherogenesis
[6,8,12,18,24,30,36-40]. Using sensitive and newly designed specific
Mg2+ ion selective electrodes, our laboratories demonstrated that
patients with hypertension, IHD, cardiac failure, strokes, diabetes
mellitus types 1 and 2, pregnant women with gestational diabetes,
renal-induced vascular changes (associated with elevated serum
cholesterol), preeclampsia, hemorrhage, sickle cell anemia in children
(and adults), and atherosclerosis exhibit significant reductions in
serum/plasma/whole blood levels of ionized, but not total blood levels
of Mg [6,8,18,40-62]. In addition, our laboratories have also shown
that dietary deficiency in rabbits and rats causes vascular remodeling
concomitant with atherogenesis (i.e., arteriolar wall hypertrophy and
alterations in the matrices of the vascular walls) and hypertension
[6,8,18,19,63-65]. These results could be considered the end result of
genotoxic effects. Some of these results have very recently been
observed to result in an acceleration of the aging process [66,67]. We
believe these latter (genotoxic?) actions of MgD are also potentially the
end result of low environmental levels of Mg in body fluids and dietary
composition. Many of the pathophysiological and pathological
molecular-biochemical alterations typically observed in tissues and
cells in the aging process have been noted in MgD tissues and cells of
the cardiovascular system by our group and some other investigators
[6,8,12,18-21,24,30,36,63,65,67-78 ].
Magnesium Deficiency Activates NF-kB and Proto-
Oncogenes, Increases Ca2+ Uptake/Release, Releases
Mitochondrial Cytochrome C, Releases Myocardial
Enzymes, as Well as Produce Reactive Oxygen Species,
Reactive Nitrogen Species and Nitric Oxide:
Relationship to Oxidized LDL, Apoptosis, Ceramide,
Cytokines, and Pathogenesis of Atherosclerosis and
Hypertension
Studies from our laboratories [8,37,69,79,80] and others [71,72,75]
have demonstrated that genotoxic reactants such as reactive oxygen
species (ROS), reactive nitrogen species and enzymes that generate
nitric oxide(e.g., eNOS and iNOS) are generated in MgD states. All of
these reactants along with movement of Ca2+ into the vascular smooth
muscle (and endothelial) cells (as a consequence of MgD)
[6,8,22,24-30,37,65,68,73,81,82] help to oxidize low density lipoprotein
(LDL) in the blood and vascular walls to promote atherogenesis. The
oxidized LDL (oxLDL) plays an important role in the pathogenesis of
atherogenesis, to a large extent, through the elevated Ca2+ ion
concentrations which contribute to blocking apoptosis of the
macrophages(normally needed to cleanse the blood of debris and
elevated lipids), thus, promoting uptake of oxLDL which then help to
transform normal contractile VSM cells to non-contractile new VSM
cell phenotypes which act to produce and synthesize a variety of
chemicals needed for the atherogenic process. Atherosclerosis is a
complicated inflammatory disorder that involves activation,
proliferation, changes in cell phenotypes (e.g., contractile VSM cells to
non-contractile synthetic cell machines) and survival of macrophages
[7,83]. In addition, for atherogenesis and hypertension to develop,
pathways for activation of NF-kB and proto-oncogenes must perforce
take place. MgD results in all of the latter in intact and in situ VSM and
myocardial cells, at least in experimental animals
[3,4,11,67,70,73,79,81,82].
The pathophysiology of hypertensive vascular disease involves
vascular remodeling via the proliferation and migration of VSM cells
[7,84]. Low [Mg2+]0 environments have been shown by our group
[6,8,18,19,65,73] and others [66,75] to promote proliferation and
migration of VSM cells. Moreover, our laboratories have demonstrated
that vascular remodeling and inflammation, at the microcirculatory
level, is seen in rabbits and rats whom are given diets low in Mg
[6,8,11,18,19,37,63-65] which are similar to the low dietary levels of
people now residing in North America and Europe. These pathological
changes clearly are a consequence of the genotoxic effects of MgD. In
cultured VSM and human endothelial cells, low Mg2+ results in the
generation and release of cytokines, chemokines, and ceramides that
are needed to mediate inflammatory events required for the initiation
of atherogenesis [3,4,6,8,11,18,67,68,7073,74,79,81]. These events were
demonstrated to involve activation of NF-kB via ROS, NOS, and nitric
oxide synthase [6,8,11,67,69,70,73,79-82]. As we predicted, inhibition
of cytokine release, inhibition of telomerase downregulation,
inhibition of ceramide generation ,inhibition of myocardial enzyme
release(i.e., lactic acid dehydrogenase, creatine kinase, troponon T),
inhibition of NF-kB activation, or inhibition of activation of proto-
oncogenes, in cultured VSM cells with excess Mg, were found to
prevent or ameliorate the toxic vascular and cardiac effects of MgD
[3,4,6,11,67,69,70,73,74,79,81].
Magnesium Deficiency Results in Oxidation and
Fragmentation of DNA, Downregulation of
Telomerase, And Increased Levels of Ceramide and
P53: Relation to Cellular Mutations and Epigenetics
Two years ago, our laboratories demonstrated, for the first time, that
21 days of low dietary Mg intake in living rats, results in a
downregulation of telomerase in cardiac and VSM muscle [67]. These
exciting results appeared to be closely related to fragmentation and
oxidation of DNA, increased cellular levels of ceramide and increased
cellular levels of the tumor suppressor gene, p53 [3,67,70,74,79]. Our
studies pointed to a sizeable cross-talk among telomerase, neutral
sphingomyelinase (N-SMase) and p53 in rat cardiac and peripheral
vascular smooth muscle exposed to short-term MgD [3,67]. We
suggested that our results would be compatible with the idea that even
short-term MgD could cause alterations of the epigenome in diverse
cell types leading to mutations of cardiac, vascular, and endothelial
cells in aging and atherogenesis. Two years ago, we suggested ways in
which this hypothesis can be tested [67]. Recently, Thakore et al. [2]
(among others) have stated "site-specific alterations of the epigenomic
landscape in eukaryotic cells are a powerful strategy for interrogating
the mechanistic relationships among chromatin state, gene regulation,
and cell phenotype”.
Importance of Mg-supplemented Drinking Water and
Beverages: Role of Adequate Mg Intake to Overcome
and Prevent Genotoxic Effects of Mg Deficiency
Over the past two -plus decades, our laboratories have
demonstrated, at least experimentally, that we can overcome all of the
genotoxic cardiovascular actions( i.e., physiological, biochemical and
Citation: Altura BM, Shah NC, Shah GJ, Altura BT (2016) Genotoxic Effects of Magnesium Deficiency in the Cardiovascular System and their
Relationships to Cardiovascular Diseases and Atherogenesis. J Cardiovasc Dis Diagn S1: 008. doi:10.4172/2329-9517.1000S1-008
Page 2 of 5
J Cardiovasc Dis Diagn Coronary Artery Disease ISSN:2329-9517 JCDD, an open access journal
molecular) of Mg deficiency in rats, rabbits and mice by either
supplementing drinking water with Mg or adding Mg to the diets fed
to the animals [3,4,6,8,18,19,67,68,74,79,81]. Our results, so far, bolster
the idea that water intake (e.g., from tap waters, well waters, bottled
waters, beverages using tap/well/spring waters, or desalinated waters)
in humans should contain at least 25-40 mg/liter/day of Mg2+ [85]. The
latter inclusion in our diets should go a long-way towards the
prevention of cardiovascular diseases and ameliorate the
atherosclerotic and inflammatory aspects of the aging process of bodily
tissues and cells in humans worldwide. Interestingly, on the basis of
our work (and some others), the World Health Organization has taken
our recommendations seriously, for the first time [86]. Lastly, this has
led Israel to supplement its desalinated drinking water, in the Southern
part of the country, with Mg2+ to determine the cardiovascular benefits
of this approach over a 5-year period [86].
Conclusion
Herein we review and present evidence for a novel, new hypothesis
on why MgD can act as a genotoxic agent and potentially cause
numerous adverse effects, even over a short-term, on the physiological,
molecular and biochemical machinery of cardiovascular tissues and
cells. The end result of such genotoxic effects of MgD probably plays
important roles in the etiology and generation of diverse
cardiovascular diseases, atherosclerosis, inflammation, and strokes via
alterations in the epigenome of these cardiovascular entities. The
importance of adequate waterborne and dietary levels of Mg is
emphasized.
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